Miraculins Closes $135,000 First Tranche of Placement

Medical Device Investing
TSXV:MOM

Miraculins Inc. (TSXV:MOM) announced has closed the first tranche of a non-brokered private placement offering of up to five million units at a price of five cents per unit for gross proceeds of up to $250,000.

Miraculins Inc. (TSXV:MOM) announced has closed the first tranche of a non-brokered private placement offering of up to five million units at a price of five cents per unit for gross proceeds of up to $250,000.
As quoted in the press release:

Each unit comprises one common share of the company and one-half of one share purchase warrant. Each whole warrant entitles the holder to purchase one share at a price of eight cents per share for a period of 12 months from the date the warrant is issued. The shares and warrants will be restricted from transfer for a period of four months and a day from the date hereof in accordance with applicable securities laws. The first closing brought in aggregate gross proceeds of $135,000 from the sale of 2.7 million units.

Connect with Miraculins Inc. (TSXV:MOM) to receive an Investor Kit

The Conversation (0)
Ă—